Aberrant PD-1/PD-L1 signaling results in the breakout of peripheral tolerance and is an important contributor to autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and encephalomyelitis (12–14). Here, CD274 is linked to rheumatoid arthritis.